X4 Pharmaceuticals, Inc. buy Cantor Fitzgerald
Start price
31.05.24
/
50%
€0.93
Target price
31.05.25
€4.61
Performance (%)
-40.71%
Price
02.10.24
€0.55
Summary
This prediction is currently active. Massive losses of -40.71% have been the result for the BUY prediction by Cantor_Fitzgerald. This prediction currently runs until 31.05.25. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
X4 Pharmaceuticals, Inc. | -13.139% | -13.139% |
iShares Core DAX® | -1.114% | 3.430% |
iShares Nasdaq 100 | 1.816% | 6.911% |
iShares Nikkei 225® | 2.113% | 5.501% |
iShares S&P 500 | 2.038% | 5.327% |
Comments by Cantor_Fitzgerald for this prediction
In the thread X4 Pharmaceuticals, Inc. diskutieren
X4 Pharmaceuticals, Inc. (NASDAQ: XFOR) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald. They now have a $5.00 price target on the stock.
Ratings data for XFOR provided by MarketBeat